Solid Tumors
20190135: A Phase 1b Study Evaluating the Safety, Tolerability, and Efficacy of Sotorasib in Combination with Panitumumab and in Combination with Panitumumab and Chemotherapy in Subjects with Advanced Solid Tumors with KRAS p.G12C Mutation (CodeBreak 101 Subprotocol H)
- Details
ClinicalTrials.gov ID:
NCT04185883
Diagnosis Type:
NA
USOR Number:
- Address
,
P: